Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris

A Prospective, Multicenter, Randomized, Controlled, Evaluator-Blinded Study of the Safety and Effectiveness of Sebacia Microparticles as an Accessory to 1064 nm Nd:Yag Laser in the Treatment of Facial Inflammatory Acne Vulgaris

Prospective, randomized, controlled, parallel group clinical study with blinded assessment evaluating Sebacia Microparticles (SM) with Nd:Yag laser in facial inflammatory acne vulgaris

Inclusion Criteria:

• Mild to moderate acne vulgaris
• At least 15 inflammatory acne lesions
• Skin phototype I - III
• Able to understand and comply with study requirements

Exclusion Criteria:

• Severe acne vulgaris
• Nodulocystic acne
• Ongoing use of medications and/or treatments for acne
• New hormone regimen (used for less than 12 weeks)
• Significant medical or mental health condition